148 related articles for article (PubMed ID: 4608944)
1. Liver disease and drug therapy.
Black M
Med Clin North Am; 1974 Sep; 58(5):1051-7. PubMed ID: 4608944
[No Abstract] [Full Text] [Related]
2. Clinical relevance of the effect of hepatic disease on drug disposition.
Bond WS
Am J Hosp Pharm; 1978 Apr; 35(4):406-14. PubMed ID: 645712
[TBL] [Abstract][Full Text] [Related]
3. Drug metabolism in liver disease.
Prescott LF; Forrest JA; Adjepon-Yamoah KK; Finlayson ND
J Clin Pathol Suppl (R Coll Pathol); 1975; 9():62-5. PubMed ID: 783214
[No Abstract] [Full Text] [Related]
4. [Pharmacokinetics in liver cirrhosis].
Ackermann E
Z Gesamte Inn Med; 1977 Jan; 32(1):29-33. PubMed ID: 855389
[TBL] [Abstract][Full Text] [Related]
5. Drug disposition in liver disease.
Fruncillo RJ
Am Fam Physician; 1982 Dec; 26(6):167-9. PubMed ID: 7148640
[No Abstract] [Full Text] [Related]
6. [Metabolism of phenylbutazone in the liver (author's transl)].
González Macías J; De Castro del Pozo S
Med Klin; 1976 Sep; 71(36):1434-8. PubMed ID: 958107
[TBL] [Abstract][Full Text] [Related]
7. [Azathioprine pharmacokinetics in animal experiment and in patients with chronic liver diseases].
Bär U; Becker H; May B; Mayer D; Ohlendorf S; Otto P; Schmidt FW
Verh Dtsch Ges Inn Med; 1973; 79():943-6. PubMed ID: 4790049
[No Abstract] [Full Text] [Related]
8. Drug disposition in liver disease.
Shand DG
N Engl J Med; 1977 Jun; 296(26):1527-8. PubMed ID: 865536
[No Abstract] [Full Text] [Related]
9. Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats.
Sawada Y; Hanano M; Sugiyama Y; Iga T
J Pharmacokinet Biopharm; 1985 Oct; 13(5):477-92. PubMed ID: 3938813
[TBL] [Abstract][Full Text] [Related]
10. [Prescription of drugs in liver diseases].
Held H
Internist (Berl); 1980 Dec; 21(12):724-34. PubMed ID: 7009474
[No Abstract] [Full Text] [Related]
11. Drug metabolism in heavy consumers of ethyl alcohol.
Iber FL
Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 2):735-42. PubMed ID: 913032
[TBL] [Abstract][Full Text] [Related]
12. [Side effects of drugs--predictable hazards for patients with liver disease].
Baumgarten R
Z Arztl Fortbild (Jena); 1983; 77(9):373-5. PubMed ID: 6880279
[No Abstract] [Full Text] [Related]
13. Interaction of phenylbutazone and tolbutamide in man.
Szita M; Gachályi B; Tornyossy M; Káldor A
Int J Clin Pharmacol Ther Toxicol; 1980 Sep; 18(9):378-80. PubMed ID: 7450929
[TBL] [Abstract][Full Text] [Related]
14. [Hepatic clearance of drugs in kidney failure].
Balant L
Nephrologie; 1983; 4(2):45-7. PubMed ID: 6136004
[No Abstract] [Full Text] [Related]
15. Drug disposition and liver disease.
Wilkinson GR; Schenker S
Drug Metab Rev; 1975; 4(2):139-75. PubMed ID: 770104
[No Abstract] [Full Text] [Related]
16. [Handling of drugs by cirrhotic patients].
Danan G; Pariente A
Rev Prat; 1986 Sep; 36(39):2298-308. PubMed ID: 3809928
[No Abstract] [Full Text] [Related]
17. [Does the elimination of medication interest the physician?].
Singlas E
Sem Hop; 1981 Oct 18-25; 57(39-40):1648-52. PubMed ID: 6119792
[No Abstract] [Full Text] [Related]
18. Defective oxidation of drugs: pharmacokinetic and therapeutic implications.
Eichelbaum M
Clin Pharmacokinet; 1982; 7(1):1-22. PubMed ID: 7042170
[No Abstract] [Full Text] [Related]
19. Impairment of drug metabolism in polycystic non-parasitic liver disease.
Sotaniemi EA; Luoma PV; Järvensivu PM; Sotaniemi KA
Br J Clin Pharmacol; 1979 Oct; 8(4):331-5. PubMed ID: 508507
[TBL] [Abstract][Full Text] [Related]
20. Impairment of drug elimination in patients with liver disease.
Narang AP; Datta DV; Mathur VS
Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):28-32. PubMed ID: 3988389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
